Immunohead Biotechnology

Company Deals

Immunohead Biotech Raises RMB 200 Million in Series A+ Financing Round

Fineline Cube Jan 3, 2023

Immunohead Biotechnology Co., Ltd, a cell therapy developer based in Suzhou, has reportedly raised close...

Company Drug

Sino Biopharm’s TQA3605 Meets Endpoint in Hepatitis B Phase II Trial

Company Drug

J&J Darzalex Faspro Gets FDA Nod for NDMM D-VRd Regimen

Company Drug

Roche CT-388 Obesity Drug Shows 22.5% Weight Loss in Phase II Trial

Policy / Regulatory

FDA Removes Suicide Warnings from GLP‑1 Drugs After Investigation Finds No Causal Link